Literature DB >> 32442308

Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study.

X Wang1, H Xu2, H Jiang3, L Wang3, C Lu4, X Wei1, J Liu2, S Xu5.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a global pandemic but the follow-up data of discharged patients was barely described. AIM: To investigate clinical outcomes, distribution of quarantine locations and the infection status of the contacts of COVID-19 patients after discharge.
DESIGN: A prospective cohort study.
METHODS: Demographics, baseline characteristics of 131 COVID-19 patients discharged from 3 February 2020 to 21 February 2020 in Wuhan, China were collected and analyzed by reviewing the medical records retrospectively. Post-hospitalization data related to clinical outcomes, quarantine locations and close contact history were obtained by following up the patients every week up to 4 weeks.
RESULTS: Fifty-three (40.05%) patients on discharge had cough (29.01%), fatigue (7.63%), expectoration (6.11%), chest tightness (6.11%), dyspnea (3.82%), chest pain (3.05%) and palpitation (1.53%). These symptoms constantly declined in 4 weeks post-discharge. Transient fever recurred in 11 (8.4%) patients. Among the discharged patients, 78 (59.5%) underwent chest CT and 2 (1.53%) showed deterioration. A total of 94 (71.8%) patients received SARS-CoV-2 retest and 8 (6.10%) reported positive. Seven (2.29%) patients were readmitted because of fever or positive SARS-CoV-2 retest. After discharge, 121 (92.37%) and 4 (3.05%) patients were self-quarantined at home or community spots, respectively, after a close contact with 167 persons in total who were free of COVID-19 at the endpoint of study.
CONCLUSION: The majority of COVID-19 patients after discharge were in the course of recovery. Readmission was required in rare cases due to suspected recurrence of COVID-19. Although no contacted infection observed, appropriate self-quarantine and regular re-examination are necessary, particularly for those who have recurred symptoms.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2020        PMID: 32442308      PMCID: PMC7313792          DOI: 10.1093/qjmed/hcaa178

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  35 in total

1.  Contentious Issue in Recurrent COVID-19 Infection: Reactivation or Reinfection.

Authors:  Manas Kamal Sen; Nitesh Gupta; Siddharth Raj Yadav; Rohit Kumar; Balvinder Singh; Pranav Ish
Journal:  Turk Thorac J       Date:  2020-11-01

2.  Immediate and short-term prevalence of depression in covid-19 patients and its correlation with continued symptoms experience.

Authors:  Ashutosh Shah; Dhiraj Bhattad
Journal:  Indian J Psychiatry       Date:  2022-06-08       Impact factor: 2.983

3.  Prevalence and Predictors of Persistent Symptoms After Clearance of SARS-CoV-2 Infection: A Multicenter Study from Egypt.

Authors:  Marwa Khalaf; Mohamed Alboraie; Muhammad Abdel-Gawad; Mohamed Abdelmalek; Ahmed Abu-Elfatth; Walaa Abdelhamed; Mariam Zaghloul; Rabab ElDeeb; Doaa Abdeltwab; Mohamed Abdelghani; Fathiya El-Raey; Hani Aboalam; Azza Badry; Mina Tharwat; Shima Afify; Doaa Elwazzan; Ahmed Shawkat Abdelmohsen; Hayam Fathy; Shaker Wagih Shaltout; Helal F Hetta; Shamardan E Bazeed
Journal:  Infect Drug Resist       Date:  2022-05-20       Impact factor: 4.177

4.  Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.

Authors:  Xiao-Hong Jin; Hui-Li Zhou; Ling-Ling Chen; Guan-Fu Wang; Qiu-Yue Han; Jian-Gang Zhang; Xia Zhang; Qiong-Yuan Chen; Yao-Han Ye; Aifen Lin; Wei-Hua Yan
Journal:  Clin Immunol       Date:  2020-11-28       Impact factor: 3.969

5.  Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature.

Authors:  Anna Gidari; Marco Nofri; Luca Saccarelli; Sabrina Bastianelli; Samuele Sabbatini; Silvia Bozza; Barbara Camilloni; Igino Fusco-Moffa; Claudia Monari; Edoardo De Robertis; Antonella Mencacci; Daniela Francisci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-10       Impact factor: 3.267

Review 6.  A Review of Prolonged Post-COVID-19 Symptoms and Their Implications on Dental Management.

Authors:  Trishnika Chakraborty; Rizwana Fathima Jamal; Gopi Battineni; Kavalipurapu Venkata Teja; Carlos Miguel Marto; Gianrico Spagnuolo
Journal:  Int J Environ Res Public Health       Date:  2021-05-12       Impact factor: 3.390

7.  Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis.

Authors:  Fauzi Yusuf; Marhami Fahriani; Sukamto S Mamada; Andri Frediansyah; Azzaki Abubakar; Desi Maghfirah; Jonny Karunia Fajar; Helnida Anggun Maliga; Muhammad Ilmawan; Talha Bin Emran; Youdiil Ophinni; Meutia Rizki Innayah; Sri Masyeni; Abdulla Salem Bin Ghouth; Hanifah Yusuf; Kuldeep Dhama; Firzan Nainu; Harapan Harapan
Journal:  F1000Res       Date:  2021-04-19

8.  Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.

Authors:  Mohammad Said Ramadan; Lorenzo Bertolino; Rosa Zampino; Emanuele Durante-Mangoni
Journal:  Clin Microbiol Infect       Date:  2021-06-23       Impact factor: 13.310

9.  Follow-up of COVID-19 recovered patients with mild disease.

Authors:  Alina Kashif; Manahil Chaudhry; Tehreem Fayyaz; Mohammad Abdullah; Ayesha Malik; Javairia Manal Akmal Anwer; Syed Hashim Ali Inam; Tehreem Fatima; Noreena Iqbal; Khadija Shoaib
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.996

10.  Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.

Authors:  César Fernández-de-Las-Peñas; Domingo Palacios-Ceña; Víctor Gómez-Mayordomo; Lidiane L Florencio; María L Cuadrado; Gustavo Plaza-Manzano; Marcos Navarro-Santana
Journal:  Eur J Intern Med       Date:  2021-06-16       Impact factor: 7.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.